Alexandro J. Martagón

ORCID: 0000-0003-2135-6295
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Lipoproteins and Cardiovascular Health
  • Diabetes, Cardiovascular Risks, and Lipoproteins
  • Cardiovascular Health and Disease Prevention
  • Cardiovascular Disease and Adiposity
  • Body Composition Measurement Techniques
  • Diet and metabolism studies
  • Health Systems, Economic Evaluations, Quality of Life
  • Cardiovascular Function and Risk Factors
  • Cancer, Lipids, and Metabolism
  • Liver Disease Diagnosis and Treatment
  • Nutritional Studies and Diet
  • Diabetes Management and Education
  • Mobile Health and mHealth Applications
  • Adipose Tissue and Metabolism
  • Diabetes and associated disorders
  • Nutrition and Health in Aging
  • Metabolism, Diabetes, and Cancer
  • Lipid metabolism and disorders
  • Adipokines, Inflammation, and Metabolic Diseases
  • Blood Pressure and Hypertension Studies
  • Health and Lifestyle Studies
  • Biomedical Ethics and Regulation
  • Diabetes Management and Research
  • Cardiovascular Health and Risk Factors
  • Diet, Metabolism, and Disease

Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán
2018-2025

Tecnológico de Monterrey
2015-2024

MSD (Mexico)
2024

European Atherosclerosis Society
2021

Houston Methodist
2011-2015

Methodist Hospital
2013

We developed a novel non-insulin-based fasting score to evaluate insulin sensitivity validated against the euglycemic-hyperinsulinemic clamp (EHC). also evaluated its correlation with ectopic fact accumulation and capacity predict incident type 2 diabetes mellitus (T2D).The discovery sample was composed by 125 subjects (57 without 68 T2D) that underwent an EHC. defined METS-IR as Ln((2*G0)+TG0)*BMI)/(Ln(HDL-c)) (G0: glucose, TG0: triglycerides, BMI: body mass index, HDL-c: high-density...

10.1530/eje-17-0883 article EN European Journal of Endocrinology 2018-03-14

The functional conversion of white adipose tissue (WAT) into a with brown (BAT)-like activity, often referred to as "browning," represents an intriguing strategy for combating obesity and metabolic disease. We demonstrate that thyroid hormone receptor (TR) activation by synthetic agonist markedly induces program adaptive thermogenesis in subcutaneous WAT coincides restoration cold tolerance cold-intolerant mice. Distinct from most other browning agents, pharmacological TR dissociates the...

10.1016/j.celrep.2015.10.022 article EN cc-by-nc-nd Cell Reports 2015-11-01

Adipose tissue distribution plays a crucial role in the development of cardiovascular complications. In particular, visceral adipose (VAT) has been linked to insulin resistance (IR) and disease (CVD). However, relationship between VAT, cardiac dysfunction meditation capacity VAT related IR not fully characterized. This cross-sectional study included adults living with type 2 diabetes (T2D). was measured using electrical bioimpedance also estimated Metabolic Score for Visceral Fat (METS-VF)....

10.1186/s12933-024-02547-x article EN cc-by-nc-nd Cardiovascular Diabetology 2025-01-02

Many pathogens colonize different anatomical sites, but the selective pressures contributing to survival in diverse niches are poorly understood. Group A Streptococcus (GAS) is a human-adapted bacterium that causes range of infections. Much effort has been expended dissect molecular basis invasive (sterile-site) infections, little known about genomes strains causing pharyngitis (streptococcal "sore throat"). Additionally, there essentially nothing genetic relationships between populations...

10.1073/pnas.1016282108 article EN Proceedings of the National Academy of Sciences 2011-03-07

Patient empowerment is a continuous process in which knowledge, motivation, and capacity to take control of their disease are built within person. This concept not always well understood applied. review describes the strategies induce patients with diabetes. In addition, most common scales used evaluate diabetes described. Furthermore, effectiveness empowerment-based interventions for improving metabolic knowledge Finally, we discuss opportunities implementation clinical practice current...

10.2147/dmso.s174910 article EN cc-by-nc Diabetes Metabolic Syndrome and Obesity 2019-08-01

Abstract Group A Streptococcus (GAS) is a human-adapted pathogen that causes variety of diseases, including pharyngitis and invasive infections. GAS strains are categorized by variation in the nucleotide sequence gene (emm) encodes M protein. To identify emm types causing Ontario, Canada, we sequenced hypervariable region 4,635 pharyngeal isolates collected during 2002–2010. The most prevalent varied little from year to year. In contrast, fine-scale geographic analysis identified inter-site...

10.3201/eid1711.110159 article EN cc-by Emerging infectious diseases 2011-11-01

Abstract The majority of cholesterol reduction therapies, such as the statin drugs, work primarily by inducing expression hepatic low-density lipoprotein receptors (LDLRs), rendering these therapeutics only partially effective in animals lacking LDLRs. Although thyroid hormones and their synthetic derivatives, often referred to thyromimetics, have been clearly shown reduce serum levels, this action has generally attributed ability increase Here we show for first time that hormone T3...

10.1210/en.2011-2081 article EN Endocrinology 2012-10-20

Hypertension is associated with insulin resistance (IR), metabolic syndrome (MS), and arterial stiffness. Non-insulin-based IR indexes were developed as tools for screening. Here, we aimed to evaluate the novel non-insulin-based Metabolic Score (METS-IR) index prediction of incident hypertension stiffness evaluated using pulse wave velocity (PWV) analysis, compared other indexes. We two populations, a cross-sectional evaluation high-risk individuals (n = 305) wide range comorbidities...

10.1111/jch.13614 article EN Journal of Clinical Hypertension 2019-07-18

Thyroid hormone receptor (TR) agonists have been proposed as therapeutic agents to treat non-alcoholic fatty liver disease (NAFLD) and insulin resistance. We investigated the ability of TR GC-1 KB2115 reduce hepatic steatosis in ob/ob mice. Both compounds markedly reduced triglyceride levels ameliorated steatosis. However, amelioration was not sufficient improve sensitivity these mice reductions triglycerides did correlate with improvements or glycemic control. Instead, effects activation on...

10.1371/journal.pone.0122987 article EN cc-by PLoS ONE 2015-04-07

Familial hypercholesterolemia (FH) is a genetic disorder driven in part by mutations three genes that encode components of the cholesterol pathway: LDLR, APOB, and PCSK9. However, majority FH genetics has been performed individuals European descent. Here, we leveraged cohort 300 patients from Mexican registry to understand how rare, high liability alleles common variants might contribute shaping individual risk. Using combination whole exome short- long-read genome sequencing, report key...

10.1101/2025.04.24.25325891 preprint EN medRxiv (Cold Spring Harbor Laboratory) 2025-04-26

Objective A haplotype at chromosome 17p13 that reduces expression and function of the solute carrier transporter SLC16A11 is associated with increased risk for type 2 diabetes in Mexicans. We aim to investigate detailed metabolic profile carriers identify potential physiological mechanisms explaining risk. Design Cross-sectional study. Methods evaluated ( n = 72) non-carriers 75) haplotype, or without diabetes. An independent sample 1069 subjects was used replicate biochemical findings. The...

10.1530/eje-18-0677 article EN European Journal of Endocrinology 2018-11-21
Roopa Mehta Alexandro J. Martagón Gabriela Ramírez Neftalí Eduardo Antonio-Villa Arsenio Vargas‐Vázquez and 60 more Daniel Elías-López Gustavo Gonzalez-Retana Bethsabel Rodríguez-Encinas José Juan Ceballos-Macías Alejandro Romero-Zazueta María R. Martínez-Alvarado Julieta D. Morales-Portano Humberto Álvarez-López Leobardo Sauque‐Reyna Laura G. Gomez-Herrera Luis E. Simental‐Mendía Humberto García‐Aguilar Elizabeth Ramírez-Cooremans Berenice Peña-Aparicio Victoria Mendoza‐Zubieta Perla A. Carrillo-González Aldo Ferreira‐Hermosillo Nacú Caracas-Portilla Guadalupe Jiménez-Domínguez Alinna Y. Ruiz-Garcia Héctor Eliud Arriaga-Cázares Jesus R. Gonzalez-Gonzalez Carla V. Mendez-Valencia Francisco G. Padilla Ramón Madriz-Prado Manuel Odin De los Ríos-Ibarra Alejandra Vázquez-Cárdenas Ruy David Arjona-Villicaña Karina J. Acevedo-Rivera Ricardo Allende-Carrera José A. Álvarez Jose C. Amezcua-Martinez Manuel de los Reyes Barrera-Bustillo Gonzalo Carazo-Vargas Roberto Contreras-Chacon Mario H. Figueroa-Andrade Ashanty Flores-Ortega Héctor García-Alcalá Laura E. Garcia de Leon Berenice García-Guzmán José de Jesús Garduño‐García Juan C. Garnica-Cuéllar José Roberto Gómez-Cruz Anell Hernandez-Garcia Jesus R. Holguin-Almada Úrsulo Juárez‐Herrera Fabiola Lugo-Sobrevilla Eduardo Márquez-Rodríguez Cristina Martı́nez-Sibaja Alma B. Medrano-Rodriguez Jose C. Morales-Oyervides Daniel I. Perez-Vazquez Eduardo Reyes-Rodríguez Ludivina Robles‐Osorio Juan Rosas-Saucedo Margarita Torres‐Tamayo Luis A. Valdez-Talavera Luis E. Vera-Arroyo Eloy Alfonso Zepeda-Carrillo Carlos A. Aguilar‐Salinas

Familial hypercholesterolemia (FH) remains underdiagnosed and undertreated. Report the results of first years (2017-2019) Mexican FH registry. There are 60 investigators, representing 28 federal states, participating in The variables included accordance with European Atherosclerosis Society (EAS) recommendations. To date, 709 patients have been registered, only 336 complete data fields presented. mean age is 50 (36-62) average time since diagnosis 4 (IQR: 2-16) years. Genetic testing...

10.1016/j.jacl.2020.12.001 article EN cc-by-nc-nd Journal of clinical lipidology 2020-12-17

OBJECTIVE To assess whether an ethnic-specific variant (p.E508K) in the maturity-onset diabetes of young (MODY) gene hepatocyte nuclear factor-1α (HNF1A) found Mexicans is associated with higher sensitivity to sulfonylureas, as documented patients MODY3. RESEARCH DESIGN AND METHODS We recruited 96 participants (46 carriers and 50 age- sex-matched noncarriers). Response glipizide (one 2.5–5.0-mg dose), metformin (four 500-mg doses), oral glucose challenge was evaluated using a previously...

10.2337/dc18-0384 article EN Diabetes Care 2018-05-29

Familial hypertriglyceridemia (FHTG) is a partially characterized primary dyslipidemia which frequently confused with other forms hypertriglyceridemia. The aim of this work to search for specific features that can help physicians recognize disease.This study included 84 FHTG cases, 728 subjects common mild-to-moderate (CHTG) and 609 normotriglyceridemic controls. All underwent genetic, clinical biochemical assessments. A set 53 single nucleotide polymorphisms (SNPs) previously associated...

10.1186/s12944-021-01436-6 article EN cc-by Lipids in Health and Disease 2021-02-15
Coming Soon ...